MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--VIVUS, Inc. (NASDAQ:VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, vice president and CFO, will present an overview of the company’s obesity and diabetes programs at the Canaccord Adams Diabetes & Obesity Conference in San Francisco.
